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Abstract
Endocytosis is an essential function of cells, with key roles in the internalisation of nutri-
ents, signal molecules and also drugs. Endocytic processes are therefore widely investi-
gated in the context of drug delivery, and inhibitors of endocytic pathways have been
used to provide information regarding uptake mechanisms of drug carrier materials. Here
we describe studies in which two established inhibitors of clathrin dependent and indepen-
dent endocytosis, chlorpromazine and methyl-β-cyclodextrin respectively, were employed
to probe endocytic pathways of three cell lines chosen to represent tumour-relevant or
associated phenotypes: 3 T3 (ﬁbroblasts), HCT 116 (colon cancer) and MGLVA-1
(gastric cancer). For clathrin mediated endocytosis the data highlight that chlorpromazine
inhibition of transferrin internalization, via clathrin dependent endocytosis, is cell and
time dependent. We also show that inhibition of uptake is transient with a resumption of
transferrin internalization after a maximal inhibition period. The same endocytosis inhib-
itors were used to probe the internalization of 50 and 100 nm carboxylated polystyrene
nanoparticles (C-PS-NPs) as model drug delivery carriers. Flow cytometry data indicated
that internalisation of C-PS-NPs varied considerably with the incubation time of cells with
chlorpromazine or methyl-β-cyclodextrin, and that the effects were also markedly cell-
line dependent. These data highlight that the effects of endocytosis inhibitors on the
internalisation pathways even of relatively simple nanoparticles are complex and interde-
pendent. We suggest that mechanistic investigations of the endocytic processes which gov-
ern practical applications of nanoparticles for diagnostic and therapeutic applications
should be considered on a cell, time and concentration basis.
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Introduction
In recent years, drug delivery systems have moved be-
yond the investigational stage to the extent that many
have now reached the market.(Peppas, 2013) Further-
more, progress in synthetic chemistry has widened the
ﬁeld of new delivery materials such that highly-deﬁned
systems can now be programmed to effect drug release
in response to disease-speciﬁc environmental changes.
(Koyamatsu et al., 2014; Zan et al., 2015) These mate-
rials may form a new class of ‘nanomedicines’ deliver-
ing and releasing drugs through patient- or disease-
related changes at the cellular and subcellular level.
(Bremer-Hoffmann et al., 2018; Chan et al., 2014; Khan
et al., 2014) However, in order to convert more of the
new carrier systems from the investigational to the
clinical phase, much greater understanding of the
mechanisms that cells use to process nanomaterials is
needed.(Li et al., 2017)
Prior reports have shown that the entry of
nanomaterials into cells, their subsequent trafﬁcking
and fate takes place via multiple, complex and some-
times overlapping endocytic routes.(Chierico et al.,
2014; Donnellan et al., 2017; Fowler et al., 2013a; Lu
et al., 2015; Moody et al., 2015; Tekle et al., 2008)
The study of novel nanoparticles intended for drug de-
livery requires that these cell mechanisms are probed
for uptake efﬁciency, pathway and kinetics.(Iversen
et al., 2011; Johnston et al., 2010) To date, the stan-
dard experiments have involved the screening of cells
with drug delivery nanoparticles (NPs) in the presence
of endocytosis inhibitors to assess the pathways of NP
internalization and trafﬁcking.(Li et al., 2015; Liu
et al., 2015; Quan et al., 2015) Typical inhibitor studies
involve their addition to cell culture media followed by
addition of labelled NPs for short periods of 1–2 hrs be-
fore obtaining a readout from, most often, ﬂow cytom-
etry or microscopy.
Here, in the speciﬁc context of nanoparticle deliv-
ery, we evaluate the use of chlorpromazine (CPZ), an
established inhibitor of clathrin mediated endocytosis
(CME), and methyl-β-cyclodextrin (MβCD), which ex-
tracts cholesterol from the membrane of cells and thus
inhibits clathrin independent pathways (CIE), including
those which take place via caveolae. We aimed to es-
tablish the activities of these inhibitors in cell lines of
relevance to cancer therapy, and across time and con-
centration ranges which might be utilised in drug deliv-
ery experiments. The iron-transport protein human
transferrin (HTf) and the lipid lactosylceramide
(LacCer) were employed as markers of CME and CIE,
respectively.(Vercauteren et al., 2010) These two in-
hibitors were tested in 3 T3 ﬁbroblasts, epithelial HCT
116 colon cancer and MGLVA-1 gastric cancer cells to
cover the intended range of potential biological tar-
gets. Carboxylated polystyrene nanoparticles (C-PS-
NPs) of 50 and 100 nm were chosen as simple, readily
available models of drug delivery carriers and their in-
ternalization was probed in these three cell lines
treated with the inhibitors at different incubation
times.
In this paper we show that the inhibition of endocy-
tosis of HTf with CPZ is markedly cell- and time- depen-
dent. In addition, the extent of inhibition is highly
dependent on the concentration of CPZ used and the
same is true for HTf internalization after inhibition.
The data further indicate that the actions of CPZ and
MβCD, which are widely used in drug delivery and cell
biology experiments, are more elaborate than com-
monly reported and that experimental protocols using
these inhibitors need to be adapted speciﬁcally for
the particular cell and carrier systems under investiga-
tion. Given the reported concerns on the low success
rates for translating lab-based nanomedicines to the
clinic, we believe the experiments reported here can
help in the search for standardised and readily transfer-
able studies of drug delivery nanoparticles in vitro.
Materials and methods
The gastric cancer cells were derived from the MGLVA-1
line –as ascites of a variant of MKN45 human gastric ad-
enocarcinoma cells and were cultured according to pro-
cedures developed in our laboratories.(Watson et al.,
1990) Other cell lines including HCT 116 human colon
cancer cells (Brattain et al., 1981), and 3 T3-Swiss al-
bino mouse embryo ﬁbroblasts were purchased from
the American Type Culture Collection (ATCC) and LGC
Standards, Teddington, UK. All cells were cultured and
recovered in Roswell Park Memorial Institute (RPMI)
medium or Dulbecco Modiﬁed Eagle Medium (DMEM)
supplemented with 10% v/v heat inactivated Foetal Bo-
vine Serum (FBS) and 2 mM L-glutamine (Sigma-Aldrich,
Dorset, UK) according to speciﬁcations from the ATCC
and Cell Bank.
The dyes BODIPY FL C5-lactosylceramide, (LacCer)
complexed to BSA,‡ and Cell Mask deep red plasma
membrane stain were purchased from Molecular Probes
‡BODIPY-labeled LacCer was applied to the cells as a complex with
BSA, which makes the lipid marker water-soluble and therefore
more easily presented to cell surfaces.
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(Paisley, UK). A speciﬁc defatted albumin preparation
(dBSA), the inhibitors chlorpromazine (CPZ), methyl-β-
cyclodextrin (MβCD) and the buffer 2-[4-(2-
hydroxyethyl)piperazin-1-yl] ethanesulfonic acid
(HEPES) were obtained from Fisher Scientiﬁc, Lough-
borough, UK.
Carboxylated polystyrene nanoparticles (C-PS-NPs)
with diameters of 50 nm (catalogue number 19775)
and 100 nm diameter (catalogue number 18791), λmax
ex 529 nm – λmax em 546 nm, were purchased as Poly-
styrene Fluoresbrite Yellow-Orange particles from
Polysciences, Heppelheim, Germany. These polystyrene
particles were similar in zeta potentials, with values of
37.7 mV for the 50 nm nanoparticles and 34.2 mV
for the 100 nm NPs.
Flow cytometry
Cells were seeded for ﬂow cytometry studies in 25cm2
vented cap ﬂasks at a concentration of 31200
cells/cm2 and allowed to attach to the bottom of the
ﬂasks overnight. In the next step, HBSS medium, sup-
plemented with 20 mM HEPES containing the appropri-
ate endocytic pathway inhibitors, or 20 mM HEPES
without inhibitors, was used to replace the full media
and incubated with the cells for 30 mins. After this
time, the solution was replaced with HBSS/HEPES
20 mM with or without lactosylceramide 0.81 μM, hu-
man transferrin 6.7 μg/ml, and the appropriate-sized
(50 or 100 nm diameter) carboxylated polystyrene
nanoparticles (C-PS-NPs). When the experimental assay
time was complete, the cells were washed again, de-
tached from the ﬂasks with trypsin–EDTA or EDTA alone,
centrifuged at 2000 g for 5 mins and re-suspended in
PFA 4% v/v in PBS as a ﬁxation buffer. An acidic cell
wash was used to remove HTf which had remained
membrane-bound after the initial washes: this
consisted of Hank’s Minimum Essential Medium devoid
of glucose +0.1% w/v NaN3 (HMEM-G) + I (2 times at
4 °C) followed by an ice cold wash for 1 min with
0.2 mM acetic acid 0.2 mM NaCl buffer. A residual acidic
solution was removed by 2 further washes with cold
HMEM-G + I. Removal of excess LacCer was via two ice
cold washes with HMEM-G + I followed by 6 rinse steps
(10 mins each) of HMEM-G + I supplemented with
5%w/v dBSA (back exchange method). A BD LSR II ﬂow
cytometer with an APC 660/20 bandpass ﬁlter for HTf
and FITC 530/30 bandpass ﬁlter for LacCer was used
to quantify ﬂuorescence in the cells resulting from
endocytosed nanoparticles.
Effects of C-PS-NPs, CPZ and MβCD on cells via
Cell Titer Glo assays
Cells were seeded at a density of 31200 cells/cm2 in the
middle 60 wells of a clear-bottom, black-sided 96 well
plate and allowed to attach to the bottom of the wells
overnight. After checking for cell attachment, the me-
dia were aspirated and replaced with 100 μl of the test
solution/suspension in HBSS/HEPES 20 mM in tripli-
cates. Three independent experiments were carried
out. For the nanoparticle uptake assays, C-PS-NPs of
50 and 100 nm were tested at concentrations of
100 μg/ml for 4 h. The endocytic pathway inhibitors
CPZ and MβCD were tested at 80 μM and 1.25 mM re-
spectively for 4.5 h. For each experiment a positive
control (PEI 0.5 mg/ml) and negative control (HBSS/
HEPES 20 mM) were also used. As a blank control, the
ﬂuorescence of HBSS/HEPES 20 mM without cells was
recorded under the same conditions. Cell suspensions
containing C-PS-NPs were incubated at 37 °C in a 5%
CO2 atmosphere for 4 h. Endocytosis inhibitors were in-
cubated with cells for 4.5 h. At a time point of 15 mi-
nutes before the experimental incubation period for
cells and particles/inhibitors was complete, the cells
were removed from the incubator and left to equili-
brate to room temperature. Subsequently, a solution
of Cell Titer Glo mix (100 μl) was applied and the 96
well plates were loaded on an orbital mixer for 2 mi-
nutes to allow sufﬁcient time for cell lysis. The plate
was further incubated at room temperature for 10 mi-
nutes to ensure a stable luminescence signal. In exper-
iments with the C-PS-NPs, the supernatants in each
well were removed with a pipette tip, and 100 μl of
HBSS/HEPES 20 mM applied, prior to the application
of the Cell Titer Glo mix. This extra step was required
to reduce possible interactions of the Cell Titer Glo en-
zyme with extracellular nanoparticles. The lumines-
cence recorded for 1 second per well according to the
manufacturer’s speciﬁcations on a FluoStar Optima mi-
croplate reader (BMG LABTECH GmbH, Ortenberg,
Germany).
Live cell imaging of C-PS-NPs in 3 T3, HCT 116
and MGLVA-1 cells via confocal microscopy
For the imaging experiments, pre-sterilised rounded
22x1.5 mm glass coverslips were placed in 6 well plates
in full media. Cells at a density of 31200 cells/cm2 were
added to the wells and allowed to attach to the glass
coverslips overnight. When attachment was conﬁrmed,
the cells were stained with Hoechst 33342 (Thermo Sci-
entiﬁc, Rockford, USA and CellMask deep red
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(Molecular Probes, Paisley, UK) cell membrane stain
(both stains at a concentration of 1 μg/ml) for 30 mi-
nutes. The media was then replaced with HBSS/HEPES
20 mM for live imaging. The microscope used for the im-
aging was a Zeiss Laser Scanning Microscope (LSM) 710,
(Jena, Germany) equipped with a heated chamber and
holders for samples (in this case coverslips) pre-
warmed to 37 °C. Microscopy images of dye-labelled
cells in buffer were taken prior to the incubation assay
of cells with the test C-PS-NPS. The polymer nanoparti-
cle suspensions were added to the buffer solution at a
1:1 ratio to obtain a ﬁnal concentration of C-PS-NPs of
50 μg/ml. In order to cover representative numbers of
cells in the images, at least 4 regions of interest for
each assay were acquired, at timepoints of 10, 20, 30
and 60 minutes using the 40x objective lens of the con-
focal microscope.
Statistics
Two way Anova statistical analysis was carried out with
GrapPad Prism 6 and Bonferroni post-analysis tests.
Results
To establish the optimal protocol for inhibiting endocy-
tosis with CPZ or MβCD we ﬁrst identiﬁed conditions for
maximal CPZ inhibition of HTf internalisation in terms
of concentration and time of incubation in 3 T3, HCT
116 and MGLVA-1 cells. For this reason, 80 μM of CPZ
was applied for 1, 2, 3 and 4 h together with HTf after
an initial HTf free 30 min preincubation. Here, the con-
centrations of the inhibitors were chosen as the highest
which inhibited HTf uptake without inducing toxicity
(Fig. S1). Initial experiments indicated that the effects
of CPZ on the endocytosis of HTf and LacSer were tem-
porary and occurred over an incubation time that was
Figure 1. Time and cell dependence of HTf uptake inhibition by CPZ or MβCD in 3 T3, HCT 116 and MGLVA-1 cells as determined by ﬂow
cytometry. Data shown are the combination of 2–6 independent experiments: mean and standard deviation of ﬂuorescence for 10000–
20000 gated cells shown for each experiment. Fluorescence was normalised against the HTf treated positive control for each period of
internalisation (considered as 100% uptake). The dotted lines refer to 50 and 100% uptake of HTf. Statistical treatments: Two-Way ANOVA
using an equation for samples of different sizes and Bonferroni post-analysis (* P < 0.05; ** P < 0.01; *** P < 0.001).
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cell-dependent (Fig. 1). HTf uptake was inhibited to
the greatest extent with CPZ at 1 and 2 h timepoints
for 3 T3 ﬁbroblasts, but at 1 h for HCT 116 cells and
4 h for MGLVA-1. Endocytosis of HTf returned to the
same levels as occurred in the absence of inhibitors af-
ter 4 h in 3 T3 and HCT 116 cells.
Furthermore, as expected, inhibition of HTf by CPZ
was concentration-dependent (Fig. 2) and again, after
a period of maximal inhibition, HTf uptake in 3 T3 and
HCT 116 cells was restored to the same levels as oc-
curred in the absence of inhibitors. This suggested
no gross toxicity of the inhibitors in these assays but
the higher concentrations of CPZ used in these studies
did increase cell recovery times as determined by HTf
internalisation. MβCD did not inhibit the internaliza-
tion of HTf at any of the timepoints chosen in these
studies.
To probe further the internalization mechanisms of
HTf after CPZ treatment, inhibition studies with HBSS
without Ca2+ and Mg2+ were carried out in 3 T3 ﬁbro-
blasts. In these conditions cells should became
energy-depleted, and thus less able to transport pro-
teins into cells by active energy-dependent pathways.
(Tarasov et al., 2012) Furthermore, the binding of li-
gands to membrane receptors and particularly the
binding of transferrin to its cognate transferrin recep-
tors, is known to be inhibited by depletion of extracel-
lular Ca.2+ (Andersen and Moestrup, 2014) The data in
Figure 3 indicate that depletion of essential ions in
these assays did not result in internalization of HTf to
the same level as occurred in cells under the initial
inhibitor-free conditions(Fig. 1). In turn, this suggested
that the restoration of HTf uptake is an energy depen-
dent process which does not occur in energy-depleted
and stressed cells. Once again no signiﬁcant effects on
HTf uptake were noted in these ﬁbroblasts incubated
with MβCD.
Subsequently, the effect of higher passage number
following the splitting of cells was studied and the ex-
tent of endocytosis inhibition was investigated in 3 T3
and HCT 116. Endocytic uptake of HTf was reduced at
passage numbers ranging between 28 and 53 in 3 T3 ﬁ-
broblasts and at passage numbers 18–44 in HCT 116.
As apparent from ﬁgure 4, CPZ was able to inhibit up-
take of HTf but this effect was diminished at higher cell
passage numbers. In addition, the difference between
inhibited and uninhibited cells was reduced and there
was found to be no statistical signiﬁcance between con-
trol and CPZ treated cells after 3 h for the higher pas-
sage 3 T3, and at all timepoints in HCT 116 cells.
Figure 2. Concentration and time dependence of HTf uptake inhibition by CPZ in 3 T3 and HCT 116 cells. Flow cytometry data normalised
against ﬂuorescence of HTf positive control and expressed at the mean and standard deviation of a minimum of 10000 gated cells for each
experiment (n = 2). The dotted lines refer to 50 and 100% uptake of HTf. Statistical treatments: Two-Way ANOVA and Bonferroni post-anal-
ysis tests for signiﬁcant differences (* P < 0.05; ** P < 0.01; *** P < 0.001).
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MβCD depletes cholesterol from plasma membranes
and previous studies have shown that uptake of the
lipid LacCer is inhibited in cells treated with this com-
pound.(Vercauteren et al., 2010) Data in Figure 5 con-
ﬁrm this, showing signiﬁcant inhibition of uptake in
the three cells lines tested, with 3 T3 cells being the
most responsive. In contrast to CPZ, the reduction of
LacCer uptake with MβCD was less dependent on cell-
passage and time. A one hour incubation period with
the drug and lipid, following a 30 min preincubation pe-
riod, resulted in the greatest reduction of endocytosis
in 3 T3 cells, whereas at least 2 h incubation was neces-
sary for HCT 116 and MGLVA-1 cells. When CPZ was used
as a control inhibitor for clathrin-independent endocy-
tosis, a substantially increased uptake of LacCer was
apparent in all cells tested. In Figure 5 the data indi-
cate that endocytosis of LacCer occurred to levels ap-
proximately 3 fold higher than those observed in the
positive control.
In the subsequent functional assays, carboxylated
polystyrene nanoparticles (C-PS-NPs) of 50 and 100 nm
nominal diameter were chosen as easily accessible
models of drug delivery carriers. Nanoparticles based
on polystyrene have been extensively studied in many
cell lines with and without attached targeting ligands
for their effects on viability and apoptosis, and also in
terms of their internalization pathways.(Fowler et al.,
2013a; Fowler et al., 2013b; Milani et al., 2012; Varela
et al., 2012) The polystyrene nanoparticles were also
similar in zeta potentials, with values of 37.7 mV for
the 50 nm nanoparticles and - 34.2 mV for the 100 nm
NPs, and thus were expected to be colloidally stable
but not to vary in uptake via a charge-dependent
mechanism.
Initial assays indicated that both types of carboxyl-
ated polystyrene nanoparticles (50 and 100 nm diame-
ter) were rapidly internalised by all 3 cell lines
(Fig. 6). Higher magniﬁcation images (Fig. 7) indicated
only minor variation in the intracellular location of
nanoparticles in the three cell lines, and nor were there
any clear differences between distribution of 50 nm vs
100 nm C-PS-NPs at either 30 minutes or 60 minutes.
However, there were some apparent differences in
sizes of punctate regions of ﬂuorescence across the cell
lines and particle size ranges over the two time periods,
potentially indicative of changes in trafﬁcking path-
ways of the nanoparticles following internalisation
(Fig. 7). In HCT116 cells the 50 nm C-PS-NPs at both
time points were localised to a tight juxtanuclear re-
gion, but 100 nm particles showed a wider distribution
proﬁle surrounding the nucleus.
The kinetics of uptake and internalization pathways
for the C-PS-NPs were therefore studied in the absence
and presence of CPZ and MβCD at time periods of 1 hr
and above (Fig. 8), as the initial experiments (Figs. 6
and 7) had suggested that maximal endocytic uptake
was rapidly reached (1 hr) in all cases.
However, because the inhibition of CME with CPZ oc-
curred at 4 h incubation in MGLVA-1 cells, we also eval-
uated uptake at a 4 h time point for this cell line. There
were wide variations in uptake of C-PS-NPs across the
cell lines when inhibitors were added compared to the
uptake in the absence of inhibitors, but statistically sig-
niﬁcant inhibition of internalization was only obtained
with 50 nm C-PS-NPs at 1 and 2 h in HCT 116 cells. This
is overall in good agreement with the times found for
inhibition of the endocytic markers HTf and LacCer. In-
triguingly, CPZ signiﬁcantly increased uptake of 100 nm
Figure 3. Effects of Ca2+ and Mg2+ depletion on the uptake of HTf with CPZ in 3 T3 cells. Results shown are represented as the mean and
standard deviation of 2 independent experiments, normalised against the HTf positive control and show the mean and the standard devi-
ation of 10000 gated cells. The dotted lines refer to 50% and 100% uptake of HTf. Error bars represent the standard deviation of the mean
of duplicate experiments, n = 2. Statistical treatments: Two-Way ANOVA and Bonferroni post-analysis test for signiﬁcant differences (*
P < 0.05; ** P < 0.01).
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C-PS-NPs at 1 hr in HCT-116 cells compared to the same
experiments without CPZ. In contrast, MβCD did not in-
hibit uptake of either size of C-PS-NPs in any cell line,
and apparent increases in uptake for the 100 nm C-PS-
NPs were not statistically signiﬁcant.
Discussion
In this study, we aimed our initial experiments on
clathrin-mediated endocytosis (CME) to focus on chlor-
promazine (CPZ), as a representative CME inhibitor.
CPZ is a dopamine antagonist and has an amphiphilic
structure enabling intercalation in the inner leaﬂet of
cell membranes.(Ferrell Jr. et al., 1988) Its cationic
portion interacts with the negative charge of phospho-
lipids and, in particular, phosphoinositides.(Chen
et al., 2003) CPZ has been reported to inhibit endocyto-
sis by binding to calmodulin, which regulates the re-
cruitment of the myristoylated alanine-rich C-kinase
substrate protein (MARCKS), which in turn acts to se-
quester the phospholipid phosphatidylinositol 4,5-
bisphosphate (PI(4,5)P2).(Marshak et al., 1985) The
process of CME requires the phospholipid in the binding
of the AP-2 adaptor protein with the plasma mem-
brane.(Eisenberg et al., 2008; Levin and Weiss, 1976)
Accordingly, when CPZ binds to calmodulin, the cas-
cade of protein and lipid recognition is disrupted and
clathrin-mediated uptake is reduced. The variations in
the inhibition times of CPZ in the different cell lines
might therefore be expected to be due to the extent
of CME activity in the cells, and accordingly the overall
levels of clathrin available. Differential increases in
MARCKS expression might also be expected to inhibit
HTf uptake more rapidly, and different cell lines have
been shown to express notably varied levels of
MARCKS.(Rose et al., 1994) However, prior studies by
Bickeboller et al. (Bickeboller et al., 2015; Rose
et al., 1994) have shown that HCT 116 cells express only
moderate levels of MARCKS, yet this cell line displayed
the quickest response to inhibition by CPZ in our stud-
ies. Different levels of calmodulin in the various cell
lines before or after exposure to CPZ or a calmodulin-
like function exploited by other proteins expressed in
immortalised and cancerous cells may also have con-
tributed to the time-dependence of HTf uptake.
(Kaneno et al., 2011) Thus while it was not altogether
surprising to observe a time-dependency of HTf uptake
inhibition, as cells inevitably will respond to the pres-
ence of a speciﬁc modulation in enzyme activity, the
ﬁnding that CPZ activity and the time-dependence of
HTf uptake varied so markedly across the 3 cell lines
was not expected.
We then evaluated the possibility that the time de-
pendency of CPZ inhibition was due to the action of ef-
ﬂux pumps pumping out CPZ in response to CPZ
perturbation of cellular functions. Indeed, the expres-
sion levels of efﬂux pumps on the plasma membrane
of cancer cells are often upregulated.(Mazard et al.,
2013) However, CPZ is known to inhibit efﬂux pumps
in addition to binding to calmodulin.(Amaral et al.,
2010; Amaral et al., 2012; Ford et al., 1989; Ford
Figure 4. Passage number and ageing of cells affects HTf uptake in
the presence of CPZ (80 μm). Graphs show inhibition with 80 μM
CPZ in 3 T3 and HCT 116 cells with more than 20 passage numbers
difference. Data represent three replicate data points for each
experiment for a minimum 2 independent experiments. Mean
and standard deviation of a minimum of two independent experi-
ments (10000 gated cells for each experiment) are shown. Statis-
tical treatment: Two-Way ANOVA using an equation for samples
of different sizes and Bonferroni post-analysis tests for signiﬁcant
differences (* P < 0.05; ** P < 0.01; *** P < 0.001).
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et al., 1990; Nacsa et al., 1998) We therefore inferred
that the mechanism by which HTf endocytosis returned
to normal levels was due to the physicochemical prop-
erties of CPZ at membranes. CPZ has been reported to
be a pore-forming molecule and has been used as a pro-
moter of membrane fusion in experiments studying the
dynamics of membrane reorganization in cells.
(Kozlovsky et al., 2002) However, it should be noted
that CPZ has been demonstrated to exhibit
membrane-fusion properties only at concentrations
near to its critical micelle concentration (4 mM),
(Mondal Roy and Sarkar, 2011) i.e. well above the con-
centrations used in our studies (which were ≤ 80 μM).
Concentrations of CPZ above 50 μM have been reported
to produce leakage of low molecular weight cytoplas-
mic materials in platelets (< 2000 Da) suggesting that
CPZ is able to produce small pores in the membrane
of cells.(Holmsen and Rygh, 1990) Nevertheless, since
Figure 5. Respective inhibition and stimulation of LacCer uptake by MβCD and CPZ. A pre-incubation step of 30 min was carried out in the
presence or absence of endocytosis inhibitors. Cells were incubated for up to 4 h and the results are the combination of 2 independent
experiments (n = 2), the error bars represent the standard deviation of the mean from a minimum of 20000 gated cells per experiment.
The dotted lines refer to 50 and 100% uptake of LacCer. Statistical treatment; T-test of CPZ or MΒCD treated cells against untreated con-
trols shows statistical signiﬁcance. (ns: non signiﬁcant, P > 0.05; *: P < 0.05; **: P < 0.01; ***: P < 0.001).
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Figure 7. Comparison of cellular location of NPs at (i) 30 minutes and (ii) 60 minutes. Scale bars are 10 μm. In the images the colours
represent the following: Green = C-PS-NPs; Red = CellMask membrane staining; Blue = Nuclei (DAPI).
Figure 6. Live cell images of the uptake of (i) 50 nm and (ii) 100 nm C-PS-NPs in 3 T3, HCT 116 and MGLVA- 1 cells before the application of
C-PS-NPs (time 0) and at, 10, 20, 30 and 60 min incubation with 50 μg/ml C-PS-NPSC-PS-NPs in HPSS/Hepes buffer 20 mM. Scale bars
represent 50 μm. In the images the colours represent the following: Green = C-PS-NPs; Red = CellMask membrane staining; Blue = Nuclei
(DAPI).
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HTf is a large and negatively charged protein (molar
mass 80 kDa, pI ~ 5.8), it is unlikely incubation of cells
with CPZ generated pores with sufﬁcient size to allow
passive transport of HTf. In addition, from the experi-
ments using CPZ at 40 and 60 μM, it was observed that
HTf uptake after inhibition returned more readily to
basal levels at lower concentrations, i.e. where any
toxicity and pore-forming ability would be reduced.
(Kilar and Simon, 1985) Further evidence that the
observed HTf internalisation did not result from overt
membrane damage was obtained from experiments
with 3 T3 cells in which media were used containing
no Ca2+ and Mg2+. In media without these two ions,
the cells were expected to become energy-depleted,
and thus less able to transport proteins into cells by ac-
tive energy-dependent pathways.(Tarasov et al., 2012)
The absence of Ca2+ in extracellular media is also
known to reduce the afﬁnity of some membrane recep-
tors to their ligands.(Andersen and Moestrup, 2014) As
expected, in the absence of these ions, no recovery of
HTf uptake was observed, with a reduction of HTf
internalization over a period of 4 h in 3 T3 cells. Taken
Figure 8. Endocytosis of 50 nm and 100 nm C-PS-NPs by cells with and without 80 μM CPZ and 1.25 mM MβCD. A pre-incubation step of
30 min was carried out in the presence or absence of endocytosis inhibitors. Cells were incubated for up to 4 h and the results are the
combination of 2 independent experiments (n = 2). Uptake of C-PS-NPs in 3 T3 and HCT 116 cells was monitored for 1 and 2 h while in
MGLVA-1 s uptake was examined at 2 and 4 h. The results are shown as the mean and standard deviation of 2 independent ﬂow cytometry
experiments obtained on 10000 gated cells (n = 2). The dotted lines refer to 50 and 100% uptake of C-PS-NPS. Statistical treatments: Two-
Way ANOVA and Bonferroni post-analysis test for signiﬁcant differences (ns: non signiﬁcant; P > 0.05: *)
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together, these data suggest that CPZ caused a tempo-
rary interruption of active and energy-dependent trans-
port processes which internalise HTf, as the subsequent
recovery of HTf endocytosis was not indicative of a gen-
eral toxicity or cell damage mechanism. Although there
might be off target effects induced by CPZ, as it is a
non-speciﬁc and complex inhibitor of endocytosis, the
pattern of HTf uptake should be considered in the con-
text of other possible transport mechanisms, such as in-
ternalization mediated via transferrin receptor 2 (TR2).
(Bramini et al., 2014; Calzolari et al., 2006; Calzolari
et al., 2007; Calzolari et al., 2009; Calzolari et al.,
2010; Johnson et al., 2007)
In addition, the data on the inhibition of CME by CPZ
showed the effects of different passage numbers of the
cell lines used on the endocytosis of HTf. The ﬁnding
that the higher the passage number or ageing of cells,
the lower the levels of endocytosis inhibition by CPZ,
may be attributed to the expression of dynamin, which
is implicated in both clathrin and caveolin endocytosis.
Levels of dynamin have been reported to be susceptible
to passage number and conﬂuence of cells.(Damke
et al., 1995) The expression of calmodulin has also been
shown to vary in relation to cell ageing and this might
have been a further factor in the variation of HTf up-
take with passage number.(Linskens et al., 1995) We
ensured that the density of cells in these experiments
was constant and at sub-conﬂuent levels and thus it
seems likely that the important determinant factor in
HTf uptake was the passage number and ageing of cells,
rather than conﬂuence per se.
CPZ was also used in LacCer inhibition studies as a
further control of CPZ speciﬁcity towards CME. Prior
literature showed that CPZ did not inhibit the uptake
of LacCer,(Ivanov, 2008) and our data were in accord
with these ﬁndings. However, in our experiments, an
increase in LacCer endocytosis was observed when CPZ
was present, which agreed with results obtained by
Vercauteren and coworkers.(Vercauteren et al., 2010)
Time dependence of the enhancement of LacCer endo-
cytosis with CPZ was apparent in 3 T3 and MGLVA-1 cells.
No dependence on passage number of cells on the
extent of the inhibition of LacCer uptake by CPZ was
observed in these experiments (data not shown). In turn
this indicates the inherent non speciﬁcity of CPZ
towards caveolin and dynamin-mediated endocytosis
in cases where passage number of cells is also a factor.
The experiments with the well-characterised protein
HTf showed some unexpected results for inhibitor activ-
ity, so it is perhaps not surprising that extension of the
Inhibitor studies to the internalization of synthetic
nanoparticles also yielded complex data. The effects
of CPZ and MβCD on the endocytosis of the C-PS-NPs
were variable across both particle sizes and in the cell-
lines studied. We originally chose the 50 and 100 nm
C-PS NPs for our study since these are colloidally stable
materials with size ranges typical of nanoparticle diag-
nostics and delivery systems, and have been used before
as model systems.(Bannunah et al., 2014; Byrne et al.,
2015) Experiments with the negatively charged polysty-
rene nanoparticles by Bannunah et al. showed that the
transport of 100 nm particles across Caco-2 and Calu-3
monolayers was suppressed by the dynamin-dependent
endocytosis inhibitor dynasore, but that uptake was
not affected.(Bannunah et al., 2014) These authors also
showed that CPZ did not affect uptake of the negatively
charged polystyrene nanoparticles, and while MβCD
reduced uptake and transport across Caco-2 and
Calu-3 monolayers, this inhibitor had no effect on
uptake in HeLa cells.(Bannunah et al., 2014) It is
notable that the effects of CPZ on the internalisation
of negatively-charged polystyrene in epithelial cells
are similar to those that we observed for 100 nm C-PS-
NPs in 3 T3 and MLGVA-1 cells, but at variance with the
results we obtained for 50 nm C-PS-NPs in HCT-116 cells.
Taken together, our observations accord with those
advocating that experimental conditions should be
carefully established in the cell lines studied, and at in-
cubation timepoints where the effects of the inhibitors
are most clearly visible.(Rodal et al., 1999) The results
shown here clearly highlight that nanoparticles can be
internalised by different mechanisms in different cell
lines and that the susceptibility to such inhibition de-
pends on the cell line and the nature of the nanoparticle
investigated. The data also highlights that in some cell
types that NP uptake can be signiﬁcantly increased by
extraction of cholesterol from the plasma membrane.
This could be further explored to identify whether this
also leads to enhancing the overall performance of NPs
when delivering small and macromolecular cargo to
deﬁned regions of a cell. It is also relevant to consider
the uptake and transport processes for diagnostic nano-
particles, for example in those which bind to cell
surface receptors and biomarkers. It has already been
shown that multivalency of ligand-surface receptor in-
teractions can alter both internalization pathways and
intracellular fate of bioconjugates and nanoparticles,
(Moody et al., 2015; Sayers et al., 2018) and thus for
any diagnostic or sensing application the ultimate desti-
nation of a nanoparticle in one cell type may be rather
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different in another cell type if the endocytic pathways
are regulated differently. In addition, for therapeutic
applications, it is clear that because there is variation
in intracellular trafﬁcking of simple nanoparticles even
in relatively well-deﬁned cell culture lines, one might
expect even more variation in human patients. The fact
that such marked differences are apparent in trafﬁcking
of nanoparticles between epithelial, ﬁbroblastic and
gastric and colon cancer cell variants suggests that
in vivo application of therapeutic nanoparticles might
require careful optimisation for individual patients also.
Conclusions
These experiments show that the effect of commonly
used chemical inhibitors on endocytosis such as CPZ
and MβCD are complex and their use should be tailored
and optimised to the cell lines used for endocytosis
studies. The study furthermore indicates that the ef-
fects of inhibitors on the internalization of endocytosis
markers and of nanoparticles is cell, time and passage
number dependent. Much of the recent literature on in-
ternalization of nanomaterials reports their route of
uptake by extrapolating results from in vitro inhibition
studies using chlorpromazine and other inhibitors of en-
docytosis. The results shown here suggest that some of
the interpretation in the literature regarding internali-
zation of nanomaterials in the presence of CPZ may
need to be expanded to take into account cell- and
time-dependency. In addition, the exact experimental
protocols for inhibition studies with CPZ need to be
evaluated carefully, and methods optimised for each
speciﬁc cell line if detailed mechanistic insight into
the endocytosis of synthetic nanomaterials is required.
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Figure S1 Cell Titer Glo toxicity tests of the working
concentrations and experimental times of incubations
used for 50 and 100 nm C-PS-NPS, CPZ and MβCD. The
seeding density of cells to obtain a linear relationship
between numbers of cells and viability signal was inves-
tigated by a titration curve prior to toxicity tests (data
not shown). Cells were seeded in 96 well plates at a
density of 31200 cells/cm2 and allowed to attach to
the wells overnight. The day after the media was re-
placed with CPZ 80 μM, MβCD 1.25 mM, 50 or 100 nm
C-PS-NPS 100 μg/ml or PEI 500 μg/ml positive control
in HBSS/HEPES 20 mM, and incubated for 4 or 4.5 h.
Upon completion of the incubation time, Cell Titer
Glo was applied according to standard protocols. Cell
Titer Glo toxicity tests were carried out in triplicate
wells in 3 independent experiments. Error bars repre-
sent the standard deviation of the mean (n = 3).
Figure 1. Time and cell dependence of HTf uptake in-
hibition by CPZ (80 μM) in 3 T3, HCT 116 and MGLVA-1
cells as determined by ﬂow cytometry. Cells were
preincubated with CPZ, MβCD or 20 mM HBSS/HEPES
for 30 mins. Then, the buffer was aspirated and re-
placed with 0.81 μM HTf in HBSS/HEPES with or without
inhibitors of endocytosis or 20 mM HBSS/HEPES alone
and further incubated for 1, 2, 3 or 4 h.
Figure 2: Concentration and time dependence of HTf
uptake inhibition by CPZ in 3 T3 and HCT 116 cells.
Cells were preincubated with HBSS/HEPES 20 mM with
or without inhibitor for 30 mins. Subsequently the pre-
treatment buffer was aspirated and 3 T3 cells were
treated with 40 and 80 μM CPZ for up to 4 h and HCT
116 with 40 and 80 μM of CPZ for up to 4 h.
Figure 3: Effects of Ca2+ and Mg2+ depletion on the up-
take of HTf with CPZ in 3 T3 cells. Cells were pre-incu-
bated with HBSS/HEPES 20 mM devoid of Ca2+ and Mg2+
with or without inhibitor for 30 mins. Subsequently the
pre-treatment buffer was aspirated and replaced with
fresh solutions of HBSS/HEPES 20 mM devoid of Ca2+
and Mg2+ with or without HTf 6.7 μg/ml, different con-
centrations of CPZ ranging from 40 to 80 μM and
1.25 mM MβCD. The cells were further incubated for
1, 2, 3 or 4 h.
Figure 4: Passage number and ageing of cells affects
HTf uptake in the presence of CPZ (80 μm). Cells
at different passage numbers were incubated with
6.7 μg/ml HTf and 80 μM CPZ at 1, 2 3 and 4 h in
3 T3 and HCT 116 cells. Graphs show inhibition with
80 μM CPZ in 3 T3 and HCT 116 cells with more than
20 passage numbers difference. Data represent three
replicate data points for each experiment for a mini-
mum 2 independent experiments. Cells were treated
as in previous experiments with 30 min pre-incubation
of CPZ or HBSS/HEPES that was replaced by
HBSS/HEPES 20 mM buffer supplemented of HTf for
the positive control or 80 μM CPZ and HTf, and further
incubated for 1 or 2 h.
Figure 5: Respective inhibition and stimulation of
LacCer uptake by MβCD and CPZ. A pre-incubation
step of 30 min was carried out in the presence or ab-
sence of endocytosis inhibitors. Upon completion of
the pre-incubation time the media was aspirated and
replaced with LacCer 0.81 μM in the presence or ab-
sence of inhibitors of endocytosis. Cells were incubated
for up to 4 h and the results are the combination of 2 in-
dependent experiments (n = 2), the error bars
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represent the standard deviation of the mean from a
minimum of 20000 gated cells per experiment.
Figure 8: Endocytosis of 50 nm and 100 nm C-PS-NPS
by cells with and without 80 μM CPZ and 1.25 mM
MβCD. A pre-incubation step of 30 min was carried out
in the presence or absence of endocytosis inhibitors.
Upon completion of the pre-incubation time the media
were aspirated and replaced with LacCer 0.81 μM in the
presence or absence of inhibitors of endocytosis. Cells
were incubated for up to 4 h and the results are the
combination of 2 independent experiments (n = 2). Inhi-
bition of uptake of C-PS-NPS in 3 T3 and HCT 116 cells
was monitored for 1 and 2 h while in MGLVA-1 s inhibi-
tion of the uptake was examined at 2 and 4 h. The re-
sults are shown as the mean and standard deviation of
2 independent ﬂow cytometry experiments obtained
on 10000 gated cells (n = 2).
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